RE:Where's the real news? Update from call:
Will file for pre-BTD in Q3 IF they get the clinical data in time.
IF accepted, they have 60 days for BTD approval (possibly Q4)
3 more candidates joining the clinical trial, bringing it to 75. Target 10 candidates more by EOY brinbging it to 85 total.
One comment that was concerning to me was regarding competition. During Rogers presentation on TLT's cash burn rate, he compared TLT to another company that has similiar clinical results and recently been granted BTD. Roger was stating that company had a 500M burn rate, but didnt go into detail on the competitions drug/treatment that was approved for BTD.
Does anyone know what this is? It sounds as if its large pharma and its results are comparable to TLT's. Considering its already been granted BTD, it will make it market way before us and they clearly dont have a funding/cashflow issue.